<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39363839</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0539</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Organic &amp; biomolecular chemistry</Title><ISOAbbreviation>Org Biomol Chem</ISOAbbreviation></Journal><ArticleTitle>Thapsigargin: a promising natural product with diverse medicinal potential - a review of synthetic approaches and total syntheses.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1039/d4ob01239a</ELocationID><Abstract><AbstractText>Thapsigargin, a sesquiterpene lactone, naturally occurring in the roots and fruits of the Mediterranean shrub <i>Thapsia garganica</i> L, is known to the practitioners of traditional medicines since the medieval ages as a cure for rheumatic pain, lung diseases, and female infertility. This naturally occurring guaianolide has shown remarkable activity for Sarco endoplasmic reticulum Ca<sup>2+</sup> ATPase inhibition, which eventually renders it fit as a potential candidate for anti-cancer drugs. Mipsagargin, a prodrug derived from thapsigargin, is under clinical trials for the treatment of glioblastoma. Recently, thapsigargin has shown promise as an antiviral against SARS-CoV-2. Limited natural availability and challenging synthesis have prompted research into new synthetic pathways. This review discusses significant synthetic approaches and total syntheses of thapsigargin reported to date.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suresh</LastName><ForeName>Anisha</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0001-5581-3485</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology (IIT), Bombay, Powai, Mumbai, 400076, India. kpk@chemiitb.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagchi</LastName><ForeName>Dibyojeet</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology (IIT), Bombay, Powai, Mumbai, 400076, India. kpk@chemiitb.ac.in.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaliappan</LastName><ForeName>Krishna P</ForeName><Initials>KP</Initials><Identifier Source="ORCID">0000-0002-0882-7155</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Indian Institute of Technology (IIT), Bombay, Powai, Mumbai, 400076, India. kpk@chemiitb.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Org Biomol Chem</MedlineTA><NlmUniqueID>101154995</NlmUniqueID><ISSNLinking>1477-0520</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363839</ArticleId><ArticleId IdType="doi">10.1039/d4ob01239a</ArticleId></ArticleIdList></PubmedData></PubmedArticle>